IPO registrations (S-1, F-1) · Registrants
CLOVER HEALTH INVESTMENTS, CORP. /DE
- SEC CIK
- 1801170 · filings on EDGAR ↗
- Former names
- Social Capital Hedosophia Holdings Corp. III (2020–2021)
- Registration
- Form S-1, first filed 2020-02-28, last 2021-11-15; 3 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2020-04-23; declared effective 2020-04-21
- Industry (SIC)
- Hospital & Medical Service Plans 6324
- Incorporated in
- DE
- Business address
- 30 MONTGOMERY STREET, Jersey City, NJ 07302
- EIN
- 98-1515192
- Ticker
- CLOV (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- CLOVER HEALTH INVESTMENTS, CORP. /DE on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2020-04-23, an initial public offering)
- Shares sold
- 72,000,000
- Gross proceeds
- $720,000,000 before underwriting discounts and any over-allotment option
- Listing
- NYSE under the symbol IPOC.U
- Lead underwriters
- Credit Suisse (72,000,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: CLOVER HEALTH INVESTMENTS, CORP. /DE EXACT (CIK (EXACT))
- Person page: Jacqueline D Reses Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other))
Filings 19
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-02-28 | S-1 | S-1 (registration) | Social Capital Hedosophia Holdings Corp. III | 0001104659-20-027174 ↗ |
| 2020-03-11 | S-1/A | S-1/A (amendment) | Social Capital Hedosophia Holdings Corp. III | 0001104659-20-031529 ↗ |
| 2020-03-18 | S-1/A | S-1/A (amendment) | Social Capital Hedosophia Holdings Corp. III | 0001104659-20-034929 ↗ |
| 2020-04-20 | S-1/A | S-1/A (amendment) | Social Capital Hedosophia Holdings Corp. III | 0001104659-20-048392 ↗ |
| 2020-04-21 | S-1MEF | S-1MEF (added securities) | Social Capital Hedosophia Holdings Corp. III | 0001104659-20-049381 ↗ |
| 2020-04-21 | EFFECT | EFFECT (declared effective) | Social Capital Hedosophia Holdings Corp. III | 9999999995-20-000806 ↗ |
| 2020-04-23 | 424B4 | 424B4 (final prospectus) | Social Capital Hedosophia Holdings Corp. III | 0001104659-20-050329 ↗ |
| 2020-12-11 | EFFECT | EFFECT (declared effective) | Social Capital Hedosophia Holdings Corp. III | 9999999995-20-003499 ↗ |
| 2021-01-13 | S-1 | S-1 (registration) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 0001193125-21-007853 ↗ |
| 2021-01-27 | EFFECT | EFFECT (declared effective) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 9999999995-21-000309 ↗ |
| 2021-06-25 | EFFECT | EFFECT (declared effective) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 9999999995-21-002525 ↗ |
| 2021-06-25 | EFFECT | EFFECT (declared effective) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 9999999995-21-002526 ↗ |
| 2021-11-15 | S-1 | S-1 (registration) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 0001628280-21-023372 ↗ |
| 2021-11-17 | S-1MEF | S-1MEF (added securities) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 0001628280-21-023762 ↗ |
| 2021-11-17 | EFFECT | EFFECT (declared effective) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 9999999995-21-004389 ↗ |
| 2021-11-18 | 424B4 | 424B4 (final prospectus) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 0001628280-21-023805 ↗ |
| 2022-02-14 | EFFECT | EFFECT (declared effective) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 9999999995-22-000442 ↗ |
| 2022-02-14 | EFFECT | EFFECT (declared effective) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 9999999995-22-000443 ↗ |
| 2022-05-20 | EFFECT | EFFECT (declared effective) | CLOVER HEALTH INVESTMENTS, CORP. /DE | 9999999995-22-001549 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-03-18 | S-1/A | registration statement | $10.00 | 60,000,000 | $600,000,000 | NYSE IPOC.U | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ | |
| 2020-04-20 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2020-04-23 | 424B4 | final prospectus | $10.00 | 72,000,000 | $720,000,000 | NYSE IPOC.U | 1 | primary document; price sentence, shares headline, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ChaChaCha SPAC C, LLC | Director,TenPercentOwner; TenPercentOwner; TenPercentOwnerOther | 3 | 2020–2021 | ||
| Osborne Ian | Director,Officer,TenPercentOwner; TenPercentOwnerOther | President | 2 | 2020–2021 | |
| Palihapitiya Chamath | Director,Officer,TenPercentOwner; TenPercentOwnerOther | CEO & Chairman of the Board | 3 | 2020–2021 | |
| Reses Jacqueline D | Director; Other | 2 | 2020–2021 | person page Fuzzy | |
| Ryans James | Director; Other | 2 | 2020–2021 | ||
| SCH Sponsor III LLC | Director,TenPercentOwner; TenPercentOwner; TenPercentOwnerOther | 3 | 2020–2021 | ||
| Trieu Steven | Officer | Chief Financial Officer | 1 | 2020 | |
| Williams Simon P.V. | Officer | General Counsel and Secretary | 1 | 2020 | |
| Clinton Chelsea | Director | 8 | 2021–2025 | ||
| Garipalli Vivek | Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Executive Officer; Executive Chairperson | 10 | 2021–2026 | |
| Lee Gia | Officer | General Counsel & Secretary | 2 | 2021 | |
| Reynoso Jamie L. | Officer | CEO, Medicare Advantage; CEO of Medicare Advantage; Chief Operating Officer | 71 | 2021–2026 | |
| SHAPIRO LEE | Director | 8 | 2021–2025 | ||
| Toy Andrew | Director,Officer | Chief Executive Officer; President; President and CTO | 33 | 2021–2026 | |
| Turner Nathaniel S. | Director | 4 | 2021–2022 | ||
| Wagner Joseph F. | Officer | Chief Financial Officer | 3 | 2021 | |
| GREENOAKS CAPITAL PARTNERS LLC | TenPercentOwner; TenPercentOwnerOther | 4 | 2021 | ||
| MEHTA NEIL | TenPercentOwner | 4 | 2021 | ||
| PERETZ BENJAMIN | TenPercentOwner | 4 | 2021 | ||
| Robinson William G Jr | Director | 8 | 2021–2026 | ||
| Kouzoukas Demetrios L. | Director | 8 | 2021–2026 | ||
| Singh Prabhdeep | Officer | Chief Growth Officer | 4 | 2021–2022 | |
| Herbers Mark | Officer | Interim CFO | 1 | 2021 | |
| Martin Joseph Richards | Officer | General Counsel | 4 | 2022–2023 | |
| Sharp Aric R | Officer | CEO of Value Based Care; CEO of Value-Based Care | 11 | 2022–2024 | |
| Priest Brady Patrick | Officer | CEO of Clover Care Services; CEO of Home Care | 28 | 2022–2026 | |
| Edwards Carladenise Armbrister | Director | 9 | 2022–2026 | ||
| Leffler Scott J. | Officer | Chief Financial Officer | 6 | 2022–2024 | |
| Loengard Anna U | Director | 11 | 2022–2026 | ||
| Wai Conrad | Officer | CEO, Counterpart Health; Chief Technology Officer | 30 | 2023–2026 | |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | Officer | Chief Technology Officer | 1 | 2023 | |
| Soares Karen | Officer | Chief Legal Officer; General Counsel & Secretary | 40 | 2023–2026 | |
| Ronan Terrence | Officer | Interim CFO | 1 | 2024 | |
| Kuipers Peter J. | Officer | Chief Financial Officer | 6 | 2024–2026 | |
| Tran Thomas L | Director | 3 | 2024–2026 | ||
| OLDAKOWSKI JOSEPH FRANK | Officer | VP OF FINANCE AND CONTROLLER | 4 | 2026 | |
| THORNTON JOSEPH CLAY | Officer | Interim CFO | 7 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | CLOVER HEALTH INVESTMENTS, CORP. /DE | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Jacqueline D Reses | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Hospital & Medical Service Plans, NJ first:
- MOLINA HEALTHCARE, INC. CA
- Alignment Healthcare, Inc. CA
- VISION HEALTH CARE INC FL
- WELLCARE HEALTH PLANS, INC. FL
- NeueHealth, Inc. FL
- COMPBENEFITS CORP GA
- Elevance Health, Inc. IN
- AMERICAN PHYSICIANS CAPITAL INC MI
- CENTENE CORP MO
- RIGHTCHOICE MANAGED CARE INC /DE MO
In other datasets, the same topic (Insurance) in NJ:
- Form D issuer: American European Group, Inc. (Form D private offerings)
- Lobbying client: AEGIS INSURANCE SERVICES, INC. (Federal lobbying (LDA))
Interests: Hospital & Medical Service Plans · Insurance